Hana Visnova

Prague, PR, Czech Republic

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Experience with intrauterine application of platelet-rich plasma in women with recurrent implantation failure.

Experience with intrauterine application of platelet-rich plasma in women with recurrent implantation failure.

Journal: Ceska gynekologie

Published: September 07, 2026

HLA-C and KIR interactions as a possible cause of reproductive failures.

HLA-C and KIR interactions as a possible cause of reproductive failures.

Journal: Ceska gynekologie

Published: January 23, 2026

A randomized, controlled, first-in-patient trial of choriogonadotropin beta added to follitropin delta in women undergoing ovarian stimulation in a long GnRH agonist protocol.

A randomized, controlled, first-in-patient trial of choriogonadotropin beta added to follitropin delta in women undergoing ovarian stimulation in a long GnRH agonist protocol.

Journal: Human reproduction (Oxford, England)

Published: October 27, 2021

A new instrument to personalize ovarian stimulation: results of the CERES study after using a novel gonadotropin - follitropin delta.

A new instrument to personalize ovarian stimulation: results of the CERES study after using a novel gonadotropin - follitropin delta.

Journal: Ceska gynekologie

Published: May 22, 2021

Current possibilities in the prevention and therapy of ovarian hyperstimulation syndrome.

Current possibilities in the prevention and therapy of ovarian hyperstimulation syndrome.

Journal: Ceska gynekologie

Published: May 22, 2021

Clinical outcomes of potential high responders after individualized FSH dosing based on anti-Müllerian hormone and body weight.

Clinical outcomes of potential high responders after individualized FSH dosing based on anti-Müllerian hormone and body weight.

Journal: Reproductive biomedicine online

Published: March 30, 2021

Effect of the oxytocin receptor antagonist nolasiban on pregnancy rates in women undergoing embryo transfer following IVF: analysis of three randomised clinical trials.

Effect of the oxytocin receptor antagonist nolasiban on pregnancy rates in women undergoing embryo transfer following IVF: analysis of three randomised clinical trials.

Journal: Human reproduction (Oxford, England)

Published: June 16, 2020

Individualization of the starting dose of follitropin delta reduces the overall OHSS risk and/or the need for additional preventive interventions: cumulative data over three stimulation cycles.

Individualization of the starting dose of follitropin delta reduces the overall OHSS risk and/or the need for additional preventive interventions: cumulative data over three stimulation cycles.

Journal: Reproductive biomedicine online

Published: May 28, 2018

Follicular and endocrine dose responses according to anti-Müllerian hormone levels in IVF patients treated with a novel human recombinant FSH (FE 999049).

Follicular and endocrine dose responses according to anti-Müllerian hormone levels in IVF patients treated with a novel human recombinant FSH (FE 999049).

Journal: Clinical endocrinology

Published: June 03, 2015

Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antimüllerian hormone-stratified, dose-response trial in women undergoing in vitro fertilization/intracytoplasmic sperm injection.

Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antimüllerian hormone-stratified, dose-response trial in women undergoing in vitro fertilization/intracytoplasmic sperm injection.

Journal: Fertility and sterility

Published: April 11, 2014

Showing 1-10 of 10

Last Updated: 09/26/2026